RecruitingPhase 4NCT06562582

STunning in Acute Myocardial Infarction - BAS

STunning in Acute Myocardial Infarction - Beta Blockers, Angiotensin Converting Enzyme Inhibitors and Sodium/Glucose Cotransporter 2 Inhibitors Trial A Low Intervention Clinical Tria

Sponsor

Vastra Gotaland Region

Enrollment

120 participants

Start Date

Jan 6, 2025

Study Type

INTERVENTIONAL

Conditions

Myocardial Infarct

Summary

The objective of this trial is to examine the effect of immediate versus late administration of beta blockers, angiotensin converting enzyme inhibitors (ACEI), and sodium/glucose cotransporter 2 (SGLT2) inhibitors on echocardiographic parameters and biomarkers in subjects with ST-elevation myocardial infarction (STEMI)

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Bisoprolol Oral Tablet, a drug called Dapagliflozin Oral Product, and others for people with myocardial infarct. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGBisoprolol Oral Tablet

Timing of drug intervention after PCI

DRUGRamipril Oral Product

Timing of drug intervention after PCI

DRUGDapagliflozin Oral Product

Timing of drug intervention after PCI

Locations(1)

Sahlgrenska University Hospital

Gothenburg, Sweden

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06562582

Related Trials

Focused Orticumab Research for Treating Inflammation in Coronary Arteries

NCT0692773941 locations

Heart Attack Blood Oxygen Therapy Trial

NCT066628901 location